文献速递细菌感染、耐药与抗菌药物

单剂epidermicin NI01可清除棉鼠鼻腔MRSA

A single dose of epidermicin NI01 is sufficient to eradicate MRSA from the nares of cotton rats.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

本研究在棉鼠鼻腔MRSA定植模型中评估新型抗菌蛋白epidermicin NI01的清除效果。单剂0.8%epidermicin与2%莫匹罗星每日两次连用3天的清除效果相当,而0.2%和0.04%每日两次连用3天无效。组织学异常为可逆性。

要点

  • 单剂0.8%epidermicin NI01清除MRSA效果与莫匹罗星相当。
  • 低浓度epidermicin每日两次连用3天对鼻腔MRSA负荷无显著影响。
  • 组织学异常为轻度至显著但可逆。

核心结论

  • 单剂局部epidermicin NI01与莫匹罗星每日两次连用3天在清除棉鼠鼻腔MRSA方面等效。

研究设计与样本

  • 棉鼠鼻腔MRSA定植模型,使用MRSA菌株ATCC 43300。
  • 比较局部0.04%和0.2%epidermicin每日两次连用3天、单剂0.8%epidermicin、2%莫匹罗星每日两次连用3天及未治疗/溶媒对照。
  • 第5天终止实验并测定MRSA定量计数,对0.2%epidermicin每日两次连用3天组组织进行组织学检查。

主要发现

  • 莫匹罗星组较溶媒组鼻腔负荷下降log10(log R)2.59 cfu/nares(P < 0.0001)。
  • 单剂0.8%epidermicin组log R为2.10 cfu/nares(P = 0.0004),与莫匹罗星等效。
  • 0.2%或0.04%epidermicin每日两次连用3天对鼻腔组织负荷无显著影响。
  • 组织学可见轻度至显著异常,但判定为可逆。

临床怎么用

  • 单剂局部epidermicin NI01有望作为MRSA鼻腔去定植的替代方案,但尚需进一步开发与临床验证。

局限性

  • 研究为棉鼠动物模型,结果不能直接外推至人体。
  • 组织学异常虽可逆,但需关注局部安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the efficacy of a potent novel antimicrobial protein of mass 6 kDa, epidermicin NI01, for eradicating the nasal burden of MRSA in a cotton rat ( Sigmodon hispidus ) model. METHODS: MRSA strain ATCC 43300 was used to establish a robust colonization of cotton rat nares. This model was used to evaluate the efficacy of topical 0.04% and 0.2% epidermicin NI01, administered twice daily for 3 days consecutively, and topical 0.8% epidermicin NI01 administered once, for reducing nasal MRSA burden. Control groups remained untreated or were administered vehicle only (0.5% hydroxypropylmethylcellulose) or 2% mupirocin twice daily for 3 days. The experiment was terminated at day 5 and MRSA quantitative counts were determined. Tissues recovered from animals treated with 0.2% epidermicin twice daily for 3 days were examined for histological changes. RESULTS: Mupirocin treatment resulted in a reduction in burden of log 10 (log R) of 2.59 cfu/nares compared with vehicle ( P < 0.0001). Epidermicin NI01 administered once at 0.8% showed excellent efficacy, resulting in a log R of 2.10 cfu/nares ( P = 0.0004), which was equivalent to mupirocin. Epidermicin NI01 administered at 0.2% or 0.04% twice daily for 3 days did not have a significant impact on the tissue burden recovered from the nares. Mild to marked histological abnormalities were noted, but these were determined to be reversible. CONCLUSION: A single dose of topical epidermicin NI01 was as effective as mupirocin administered twice daily for 3 days in eradication of MRSA from the nares of cotton rats. This justifies further development of epidermicin for this indication.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Halliwell S, Warn P, Sattar A, et al. A single dose of epidermicin NI01 is sufficient to eradicate MRSA from the nares of cotton rats. J Antimicrob Chemother. 2017. PMID: 27999015. doi:10.1093/jac/dkw457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。